#ESMO26: Risvutatug rezetecan improves PFS in relapsed/refractory osteosarcoma. Dr Lu Xie discusses the findings with ecancer. Watch here: https://ecancer.org/en/video/13120-risvut

ecancer· @ecancer · X·2026-10-27 02:01· 2 days agoScore70

Body

#ESMO26: Risvutatug rezetecan improves PFS in relapsed/refractory osteosarcoma. Dr Lu Xie discusses the findings with ecancer. Watch here: https://ecancer.org/en/video/13120-risvutatug-rezetecan-improves-pfs-in-relapsed-or-refractory-osteosarcoma #oncology #Osteosarcoma #OncologyResearch @PKU1898

20 views · 0 likes · 0 reposts · 0 replies

Conference abstracts

LBA13matched by Proffered paper 1: Breast cancer, early and advanced stage

Trastuzumab rezetecan (SHR-A1811) in HER2-low advanced breast cancer (BC): A randomized, phase 3 study (HORIZON-Breast06)

https://esmocongress.esmo.org

Source: ecancer · x.com